40 related articles for article (PubMed ID: 32327702)
1. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract][Full Text] [Related]
2. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer.
Kinnaird A; Yerram NK; O'Connor L; Brisbane W; Sharma V; Chuang R; Jayadevan R; Ahdoot M; Daneshvar M; Priester A; Delfin M; Tran E; Barsa DE; Sisk A; Reiter RE; Felker E; Raman S; Kwan L; Choyke PL; Merino MJ; Wood BJ; Turkbey B; Pinto PA; Marks LS
J Urol; 2022 Apr; 207(4):823-831. PubMed ID: 34854746
[TBL] [Abstract][Full Text] [Related]
4. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.
Murphy AB; Carbunaru S; Nettey OS; Gornbein C; Dixon MA; Macias V; Sharifi R; Kittles RA; Yang X; Kajdacsy-Balla A; Gann P
Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993
[TBL] [Abstract][Full Text] [Related]
5. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance.
Perera M; Jibara G; Tin AL; Haywood S; Sjoberg DD; Benfante NE; Carlsson SV; Eastham JA; Laudone V; Touijer KA; Fine S; Scardino PT; Vickers AJ; Ehdaie B
Eur Urol Focus; 2023 Jul; 9(4):662-668. PubMed ID: 36566100
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
Lange JM; Laviana AA; Penson DF; Lin DW; Bill-Axelson A; Carlsson SV; Newcomb LF; Trock BJ; Carter HB; Carroll PR; Cooperberg MR; Cowan JE; Klotz LH; Etzioni RB
Cancer; 2020 Feb; 126(3):583-592. PubMed ID: 31639200
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer.
Gandaglia G; Leni R; Plagakis S; Stabile A; Montorsi F; Briganti A
BMC Urol; 2023 Sep; 23(1):153. PubMed ID: 37777767
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
Berman DM; Lee AY; Lesurf R; Patel PG; Ebrahimizadeh W; Bayani J; Lee LA; Boufaied N; Selvarajah S; Jamaspishvili T; Guérard KP; Dion D; Kawashima A; Clarke GM; How N; Jackson CL; Scarlata E; Siddiqui K; Okello JBA; Aprikian AG; Moussa M; Finelli A; Chin J; Brimo F; Bauman G; Loblaw A; Venkateswaran V; Buttyan R; Chevalier S; Thomson A; Park PC; Siemens DR; Lapointe J; Boutros PC; Bartlett JMS
J Urol; 2023 Aug; 210(2):257-271. PubMed ID: 37126232
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathologic factors predicting reclassification in active surveillance cohorts.
Sierra PS; Damodaran S; Jarrard D
Int Braz J Urol; 2018; 44(3):440-451. PubMed ID: 29368876
[TBL] [Abstract][Full Text] [Related]
11. Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients.
Lin PH; Howard L; Freedland SJ
J Urol; 2021 Sep; 206(3):499-501. PubMed ID: 33819069
[No Abstract] [Full Text] [Related]
12. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
Deka R; Courtney PT; Parsons JK; Nelson TJ; Nalawade V; Luterstein E; Cherry DR; Simpson DR; Mundt AJ; Murphy JD; D'Amico AV; Kane CJ; Martinez ME; Rose BS
JAMA; 2020 Nov; 324(17):1747-1754. PubMed ID: 33141207
[TBL] [Abstract][Full Text] [Related]
13. The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016.
Desmond C; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Aghdam N; Olumi AF; Gershman B
Prostate Cancer Prostatic Dis; 2024 Mar; ():. PubMed ID: 38555410
[TBL] [Abstract][Full Text] [Related]
14. Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysis.
Awasthi S; Mahal BA; Park JY; Creed JH; Williams VL; Elkenawi A; Meadows SO; Pow-Sang JM; Lu-Yao G; Kelly WK; Lang DY; Zgibor J; Rebbeck TR; Yamoah K
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):547-552. PubMed ID: 35194179
[TBL] [Abstract][Full Text] [Related]
15. Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study.
Hoffman RM; Mott SL; McDowell BD; Anand ST; Nepple KG
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):100-108. PubMed ID: 34108645
[TBL] [Abstract][Full Text] [Related]
16. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer.
Vitzthum LK; Nalawade V; Riviere P; Sumner W; Nelson T; Mell LK; Furnish T; Rose B; Martínez ME; Murphy JD
JCO Oncol Pract; 2021 Jun; 17(6):e703-e713. PubMed ID: 33534647
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage.
Etzioni R; Nyame YA
J Natl Cancer Inst; 2021 Jun; 113(6):650-651. PubMed ID: 33146382
[No Abstract] [Full Text] [Related]
18. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
Deka R; Parsons JK; Simpson DR; Riviere P; Nalawade V; Vitzthum LK; Kader AK; Kane CJ; Rock CS; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):581-588. PubMed ID: 32327702
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.
Jayadevan R; Felker ER; Kwan L; Barsa DE; Zhang H; Sisk AE; Delfin M; Marks LS
JAMA Netw Open; 2019 Sep; 2(9):e1911019. PubMed ID: 31509206
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
